zur Startseite

IWWM10 - New York - 2018

We thank Steven Treon and his team for organizing the fantastic IWWM10 in New York in October this year. A great meeting and motivation for all of us to continue our efforts to improve treatment of WM


Presentations on WM at this year‘s ASH 2013 in New Orleans

from our consortium on:

  • Elevated Von Willebrand Factor Antigen Serum Levels and their association with poor prognosis In patients with symptomatic Waldenstrom’s Macroglobulinemia  (Efstathios Kastritis et al., Athens, Greece)
  • Disease unrelated mortality accounting for differences in survival in patients >75 Years with symptomatic Waldenström’s Macroglobulinemia  (Efstathios Kastritis et al., Athens, Greece)
  • Newest update of the WM2 trial on the efficacy of Bortezomib in patients with advanced Waldenström Macroglobulinemia  (V. Leblond et al., Paris, France)
‹ back